SymBio Pharmaceuticals Limited

4582.T
Drug Manufacturers - Specialty & Generic
2026/09/22 Updated
Market Cap: $28.0M (¥4.4B)
Stock Price: $0.35 (¥55)
Exchange Rate: 1 USD = ¥157.23

Notice on the Completion of Payment for the 2nd Unsecured Ordinary Bond (Private Placement)

Total amount of the 2nd unsecured ordinary bond (private placement) issued and paid in is 100,000,000 yen. Maturity date is September 3, 2029, interest rate 0%, late surcharge 20%. Issuer is EVO FUND, with related transactions involving new share subscription rights issued to a third party.

Importance:
Page Updated: September 22, 2026
IR Disclosure Date: September 3, 2026

Key Figures

  • Total bonds: 100,000,000 yen
  • Maturity date: September 3, 2029
  • Interest rate: annual rate 0%

AI要約

Overview

This bond was issued as the 2nd unsecured ordinary bond (private placement), with a total amount of 100,000,000 yen, and units of 2,500,000 yen each. Payment date is September 3, 2026, maturity date is September 3, 2029. Interest rate is 0%, late payment penalty is 20% per year. Issuer is EVO FUND, including related transactions involving third-party allocated warrants.

Future measures/conditions

Repayment method is a lump-sum at maturity. There may be a call option under certain conditions, and there are detailed provisions for adjustments if warrants are exercised and related payments occur.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

SymBio Pharmaceuticals Limited

Company overview · Stock price · Financial data · All IR

View company page →